Expression of the chromatin remodeling factor Rsf-1 is down-regulated in breast carcinoma effusions

Human Pathology

Volumn 39, Issue 4, 2008, Pages 616-622

  Davidson, Ben ^a,c   Wang, Tian Li ^b   Shih, Ie Ming ^b   Berner, Aasmund ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Breast carcinoma; Chromatin remodeling; Effusions; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLINICAL FEATURE; CONTROLLED STUDY; EFFUSION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE; ONCOGENE NEU; OVARY CARCINOMA; PROTEIN EXPRESSION; RSF 1 GENE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; DOWN-REGULATION; EXTRACELLULAR FLUID; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; RECEPTOR, ERBB-2; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 40649107604     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.09.008     Document Type: Article

References (24)

1. Hausheer F.H., and Yarbro J.W. Diagnosis and treatment of malignant pleural effusion. Semin Oncol 12 (1985) 54-75
2. Martinez-Moragon E., Aparicio J., Sanchis J., Menendez R., Cruz Rogado M., and Sanchis F. Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases. Respiration 65 (1998) 108-113
3. Wilkes J.D., Fidias P., Vaickus L., and Perez R.P. Malignancy-related pericardial effusion. 127 cases from the Roswell Park Center Institute. Cancer 76 (1995) 1377-1387
4. Dieterich M., Goodman S.N., Rojas-Corona R.R., Emralino A.B., Jimenez-Joseph D., and Sherman M.E. Multivariate analysis of prognostic features in malignant pleural effusions from breast cancer patients. Acta Cytol 38 (1994) 945-952
5. Banerjee A.K., Willetts I., Robertson J.F., and Blamey R.W. Pleural effusion in breast cancer: a review of the Nottingham experience. Eur J Surg Oncol 20 (1994) 33-36
6. Cho K.S., Elizondo L.I., and Boerkoel C.F. Advances in chromatin remodeling and human disease. Curr Opin Genet Dev 14 (2004) 308-315
7. Wong A.K., Shanahan F., Chen Y., et al. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 60 (2000) 6171-6177
8. Xu J., and Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 17 (2003) 1681-1692
9. Kumar R., Wang R.A., and Bagheri-Yarmand R. Emerging roles of MTA family members in human cancers. Semin Oncol 30 (2003) 30-37
10. Dobrzycka K.M., Townson S.M., Jiang S., and Oesterreich S. Estrogen receptor corepressors-a role in human breast cancer?. Endocr Relat Cancer 10 (2003) 517-536
11. Loyola A., Huang J.-Y., LeRoy G., et al. Functional analysis of the subunits of the chromatin assembly factor RSF. Mol Cell Biol 23 (2003) 6759-6768
12. LeRoy G., Orphanides G., Lane W.S., and Reinberg D. Requirement of RSF and FACT for transcription of chromatin templates in vitro. Science 282 (1998) 1900-1904
13. Shamay M., Barak O., Doitsh G., Ben-Dor I., and Shaul Y. Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription. J Biol Chem 277 (2002) 9982-9988
14. Shamay M., Barak O., and Shaul Y. HBXAP, a novel PHD-finger protein, possesses transcription repression activity. Genomics 79 (2002) 523-529
15. Wang T.L., Maierhofer C., Speicher M.R., et al. Digital karyotyping. Proc Natl Acad Sci U S A 99 (2002) 16156-16161
16. Shih Ie.M., Sheu J.J., Santillan A., et al. Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma. Proc Natl Acad Sci U S A 102 (2005) 14004-14009
17. Davidson B., Trope' C.G., Wang T.L., and Shih Ie.M. Expression of the chromatin remodeling factor Rsf-1 in effusions is a novel predictor of poor survival in ovarian carcinoma. Gynecol Oncol 103 (2006) 814-819
18. Elston C.W., and Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19 (1991) 403-410
19. Davidson B., Nielsen S., Christensen J., et al. The role of Desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 25 (2001) 1405-1412
20. Davidson B., Konstantinovsky S., Nielsen S., et al. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients-a novel model for tumor progression. Clin Cancer Res 10 (2004) 7335-7346
21. Mao T.L., Hsu C.Y., Yen M.J., et al. Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma. Hum Pathol 37 (2006) 1169-1175
22. Davidson B., Reich R., Lazarovici P., Flørenes V.A., Nielsen S., and Nesland J.M. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provides the first evidence of tumor progression to effusion in breast carcinoma. Breast Cancer Res Treat 83 (2004) 119-128
23. Konstantinovsky S., Nielsen S., Vyberg M., et al. Angiogenic molecule expression is downregulated in effusions from breast cancer patients. Breast Cancer Res Treat 94 (2005) 71-80
24. Davidson B., Konstantinovsky S., Kleinberg L., et al. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma. Gynecol Oncol 102 (2006) 453-461